Tom Roseberry

Co-founder & CTO @ Olio Labs

Co-founder

Olio Labs· Summer 2023 🇺🇸 Palo Alto, California, United States

in LinkedIn 𝕏 @tomroseberry789

2023Co-founder· Olio Labs

Founder · since 2023

Company

Olio Labs

Role

Co-Founder & CTO

current

Stage

—

no public source

Raised

—

no public source

Based

San Francisco Bay Area

current

Founder / co-founder — the company's markEmployee / research role

Source: LinkedIn work history

Profile coverage5 of 7 · missing posts, contact

Olio Labs

Combination therapeutics for the world's toughest diseases

Summer 2023

Experience

Career

Olio Labs
Co-founder
Co-Founder & CTO · San Francisco Bay Area · 2023 – Present
2023
Pioneer Fund
Venture Partner · San Francisco Bay Area · 2023 – Present
2023
Cellular Longevity, Inc., dba Loyal
Advisor · San Francisco Bay Area · 2022
2022
Cellular Longevity, Inc., dba Loyal
VP of Engineering, Computational Biology and Drug Development · San Francisco, California, United States · 2021 – 2022
2021
Cellular Longevity, Inc., dba Loyal
Director of Computational Biology · San Francisco Bay Area · 2021
2021
Loyal
Head of Quantitative Research & Bioinformatics · San Francisco Bay Area · 2021
2021
CODA Biotherapeutics
Senior Scientist - Discovery | Bioinformatics | Translation · San Francisco, CA · 2020 – 2021
2020
Phil and Penny Knight Campus for Accelerating Scientific Impact at the University of Oregon
Senior Research Engineer · Eugene, Oregon · 2019
2019
Neuralink
Member of Technical Staff · San Francisco Bay Area · 2018 – 2019
2018
UC Berkeley Electrical Engineering & Computer Sciences (EECS)
Postdoctoral Researcher · Berkeley, CA · 2017 – 2018
2017
University of California, San Francisco
Graduate Student Researcher · 2012 – 2017
2012
University of San Francisco
Adjunct Professor - Physics · san Francisco, CA · 2013 – 2017
2013
Cycle University
Head Triathlon Coach · Seattle, WA · 2009 – 2012
2009
Electroimpact
Mechanical Engineer · Mukilteo, WA · 2005 – 2009
2005

Bio

Tom has over 15 years of industry experience leading teams and engineering technologies in aerospace, brain machine interfacing, synthetic biology and drug discovery/development. At Neuralink he built and co-led a group that developed a next-generation neural interface. At Loyal he built and led multiple teams as VP of Engineering, Computational Biology and Drug Development.